Viatris Reports Tomorrow With Momentum That Still Hasn't Convinced Anyone It Will Last
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Viatris reports before market open, meaning Day 0 captures the market's immediate reaction during the first trading session after results are released, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | +$1.44 (+9.03%) | $1.09 (6.87%) | -$0.22 (-1.27%) | $0.88 (5.06%) |
| 2026-02-26 | -$0.83 (-5.16%) | $1.33 (8.27%) | -$0.32 (-2.10%) | $0.65 (4.27%) |
| 2025-11-06 | -$0.64 (-5.95%) | $0.92 (8.56%) | +$0.01 (+0.10%) | $0.24 (2.37%) |
| 2025-08-07 | +$0.64 (+7.31%) | $0.64 (7.37%) | +$0.31 (+3.30%) | $0.48 (5.11%) |
| 2025-05-08 | +$0.49 (+5.70%) | $0.66 (7.73%) | -$0.32 (-3.52%) | $0.57 (6.27%) |
| 2025-02-27 | -$1.71 (-15.21%) | $1.04 (9.25%) | -$0.30 (-3.15%) | $0.62 (6.51%) |
| 2024-11-07 | +$1.57 (+13.52%) | $1.77 (15.25%) | -$0.22 (-1.67%) | $0.48 (3.64%) |
| 2024-08-08 | +$0.74 (+6.51%) | $0.89 (7.83%) | -$0.32 (-2.64%) | $0.34 (2.81%) |
| Avg Abs Move | 8.55% | 8.89% | 2.22% | 4.50% |
Historical price action around Viatris earnings shows significant volatility, with an average absolute Day 0 move of 8.55% and Day 0 range of 8.89%. The direction has been mixed but leans positive in recent quarters—the most recent Q1 2026 report triggered a strong +9.03% Day 0 rally, while Q4 2025 saw a -5.16% decline despite a modest earnings beat.
The data reveals that initial reactions can be dramatic, with moves ranging from -15.21% (Q4 2024) to +13.52% (Q3 2024), suggesting the market is highly sensitive to not just the earnings beat/miss but also guidance, margin trends, and commentary on key growth initiatives. Day +1 follow-through is more muted, averaging 2.22%, indicating most of the price discovery occurs in the immediate post-earnings session. Investors should prepare for potential volatility in the 6-9% range based on historical patterns.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 16) |
| Expected Move | $1.22 (6.93%) |
| Expected Range | $16.43 to $18.87 |
| Implied Volatility | 48.06% |
The options market is pricing an expected move of 6.93% ($1.22) for the August 21 expiration, which sits below the stock's average historical Day 0 move of 8.55%. This suggests options traders are anticipating a more moderate reaction than the historical average, though still meaningful volatility. The 16-day window to expiration and 48.06% average volatility indicate elevated uncertainty heading into the print.
Part 3: What Analysts Are Saying
Analysts maintain a cautiously optimistic stance on Viatris, with a consensus rating of 3.78 (between Hold and Buy) and an average price target of $18.44. This target implies approximately 4.5% upside from the current price of $17.65, suggesting modest appreciation potential in the near term.
The analyst community is divided in its conviction, with 4 Strong Buy ratings and 4 Hold ratings, balanced by 1 Moderate Sell. This 4-4-1 split reflects differing views on the company's ability to navigate generic pricing pressure while scaling its biosimilar portfolio. The price target range is notably wide, spanning from a low of $12.00 to a high of $23.00, indicating significant disagreement about the company's valuation and growth trajectory.
Sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 3.78. This stability suggests analysts are in wait-and-see mode ahead of the Q2 report, looking for evidence that recent operational momentum can be sustained. The lack of recent upgrades or downgrades indicates the Street is comfortable with current expectations but needs confirmation through results and guidance before adjusting views materially.
Part 4: Technical Picture
Viatris enters earnings with strong technical momentum, as the Barchart Technical Opinion shows a 100% Buy signal—unchanged from both one week and one month ago. This consistent bullish reading reflects sustained upward momentum as the stock approaches its quarterly report.
Timeframe Analysis:
- Short-term (100% Buy): Strong buy signal indicates robust near-term momentum heading into the earnings event
- Medium-term (100% Buy): Continued strength in the intermediate timeframe suggests the uptrend is well-established beyond just short-term trading
- Long-term (100% Buy): Maximum bullish reading across the longer-term horizon reflects a sustained structural uptrend
Trend Characteristics: The combination of Strong strength and Average direction suggests a powerful but measured uptrend, indicating the stock is advancing with conviction rather than experiencing parabolic or unsustainable moves.
The moving average structure confirms this bullish setup. VTRS trades at $17.65, positioned above its 10-day ($17.61), 20-day ($17.22), 50-day ($16.54), 100-day ($15.63), and 200-day ($14.06) moving averages—a textbook bullish alignment. The stock sits just slightly below its 5-day average ($17.66), suggesting minor near-term consolidation within a broader uptrend.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $17.66 | 50-Day MA | $16.54 |
| 10-Day MA | $17.61 | 100-Day MA | $15.63 |
| 20-Day MA | $17.22 | 200-Day MA | $14.06 |
The 25.6% gain above the 200-day moving average demonstrates the strength of the rally since earlier in the year, while the tight clustering of shorter-term averages suggests recent momentum remains intact without becoming overextended. The technical setup is supportive heading into earnings, with the stock in a confirmed uptrend across all major timeframes. However, the strong pre-earnings run also means VTRS has less cushion for disappointment—any miss or weak guidance could trigger profit-taking from a technically overbought position. The bullish alignment favors continued strength if results and outlook meet or exceed expectations.